vs
PROGRESS SOFTWARE CORP（PRGS）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
PROGRESS SOFTWARE CORP的季度营收约是Ultragenyx Pharmaceutical Inc.的1.2倍（$252.7M vs $207.3M），PROGRESS SOFTWARE CORP净利率更高（10.2% vs -62.0%，领先72.2%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 17.5%），PROGRESS SOFTWARE CORP自由现金流更多（$59.9M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 17.0%）
Progress Software是全球领先的企业级软件服务商，主营应用开发平台、数据连接工具、数字体验解决方案等产品，服务覆盖金融、医疗、制造、零售等多行业的全球企业客户，助力客户搭建高性能可扩展的业务应用，提升运营效率。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
PRGS vs RARE — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $252.7M | $207.3M |
| 净利润 | $25.7M | $-128.6M |
| 毛利率 | 81.6% | — |
| 营业利润率 | 15.2% | -54.7% |
| 净利率 | 10.2% | -62.0% |
| 营收同比 | 17.5% | 25.9% |
| 净利润同比 | 2144.6% | 3.5% |
| 每股收益（稀释后） | $0.59 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $252.7M | $207.3M | ||
| Q3 25 | $249.8M | $159.9M | ||
| Q2 25 | $237.4M | $166.5M | ||
| Q1 25 | $238.0M | $139.3M | ||
| Q4 24 | $215.0M | $164.6M | ||
| Q3 24 | $178.7M | $139.5M | ||
| Q2 24 | $175.1M | $147.0M | ||
| Q1 24 | $184.7M | $108.8M |
| Q4 25 | $25.7M | $-128.6M | ||
| Q3 25 | $19.4M | $-180.4M | ||
| Q2 25 | $17.0M | $-115.0M | ||
| Q1 25 | $10.9M | $-151.1M | ||
| Q4 24 | $1.1M | $-133.2M | ||
| Q3 24 | $28.5M | $-133.5M | ||
| Q2 24 | $16.2M | $-131.6M | ||
| Q1 24 | $22.6M | $-170.7M |
| Q4 25 | 81.6% | — | ||
| Q3 25 | 81.0% | — | ||
| Q2 25 | 80.1% | — | ||
| Q1 25 | 80.6% | — | ||
| Q4 24 | 83.0% | — | ||
| Q3 24 | 83.7% | — | ||
| Q2 24 | 81.7% | — | ||
| Q1 24 | 82.2% | — |
| Q4 25 | 15.2% | -54.7% | ||
| Q3 25 | 17.6% | -106.9% | ||
| Q2 25 | 16.3% | -64.8% | ||
| Q1 25 | 13.6% | -102.6% | ||
| Q4 24 | 10.0% | -74.3% | ||
| Q3 24 | 22.6% | -94.6% | ||
| Q2 24 | 15.5% | -79.1% | ||
| Q1 24 | 19.0% | -151.9% |
| Q4 25 | 10.2% | -62.0% | ||
| Q3 25 | 7.8% | -112.8% | ||
| Q2 25 | 7.2% | -69.0% | ||
| Q1 25 | 4.6% | -108.5% | ||
| Q4 24 | 0.5% | -80.9% | ||
| Q3 24 | 15.9% | -95.7% | ||
| Q2 24 | 9.2% | -89.5% | ||
| Q1 24 | 12.3% | -156.8% |
| Q4 25 | $0.59 | $-1.28 | ||
| Q3 25 | $0.44 | $-1.81 | ||
| Q2 25 | $0.39 | $-1.17 | ||
| Q1 25 | $0.24 | $-1.57 | ||
| Q4 24 | $0.01 | $-1.34 | ||
| Q3 24 | $0.65 | $-1.40 | ||
| Q2 24 | $0.37 | $-1.52 | ||
| Q1 24 | $0.51 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $94.8M | $421.0M |
| 总债务越低越好 | $1.4B | — |
| 股东权益账面价值 | $478.3M | $-80.0M |
| 总资产 | $2.5B | $1.5B |
| 负债/权益比越低杠杆越低 | 2.93× | — |
8季度趋势，按日历期对齐
| Q4 25 | $94.8M | $421.0M | ||
| Q3 25 | $99.0M | $202.5M | ||
| Q2 25 | $102.0M | $176.3M | ||
| Q1 25 | $124.2M | $127.1M | ||
| Q4 24 | $118.1M | $174.0M | ||
| Q3 24 | $232.7M | $150.6M | ||
| Q2 24 | $190.4M | $480.7M | ||
| Q1 24 | $133.2M | $112.3M |
| Q4 25 | $1.4B | — | ||
| Q3 25 | $1.4B | — | ||
| Q2 25 | $1.5B | — | ||
| Q1 25 | $1.5B | — | ||
| Q4 24 | $1.5B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $478.3M | $-80.0M | ||
| Q3 25 | $477.7M | $9.2M | ||
| Q2 25 | $452.7M | $151.3M | ||
| Q1 25 | $431.8M | $144.2M | ||
| Q4 24 | $438.8M | $255.0M | ||
| Q3 24 | $425.6M | $346.8M | ||
| Q2 24 | $401.7M | $432.4M | ||
| Q1 24 | $461.7M | $140.3M |
| Q4 25 | $2.5B | $1.5B | ||
| Q3 25 | $2.4B | $1.2B | ||
| Q2 25 | $2.4B | $1.3B | ||
| Q1 25 | $2.5B | $1.3B | ||
| Q4 24 | $2.5B | $1.5B | ||
| Q3 24 | $1.6B | $1.5B | ||
| Q2 24 | $1.6B | $1.6B | ||
| Q1 24 | $1.5B | $1.3B |
| Q4 25 | 2.93× | — | ||
| Q3 25 | 2.97× | — | ||
| Q2 25 | 3.22× | — | ||
| Q1 25 | 3.50× | — | ||
| Q4 24 | 3.48× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $62.8M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $59.9M | $-100.8M |
| 自由现金流率自由现金流/营收 | 23.7% | -48.6% |
| 资本支出强度资本支出/营收 | 1.1% | 0.5% |
| 现金转化率经营现金流/净利润 | 2.44× | — |
| 过去12个月自由现金流最近4个季度 | $229.5M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $62.8M | $-99.8M | ||
| Q3 25 | $73.4M | $-91.4M | ||
| Q2 25 | $30.0M | $-108.3M | ||
| Q1 25 | $68.9M | $-166.5M | ||
| Q4 24 | $19.7M | $-79.3M | ||
| Q3 24 | $57.7M | $-67.0M | ||
| Q2 24 | $63.7M | $-77.0M | ||
| Q1 24 | $70.5M | $-190.7M |
| Q4 25 | $59.9M | $-100.8M | ||
| Q3 25 | $72.4M | $-92.7M | ||
| Q2 25 | $29.5M | $-110.7M | ||
| Q1 25 | $67.7M | $-167.8M | ||
| Q4 24 | $16.8M | $-79.5M | ||
| Q3 24 | $56.6M | $-68.6M | ||
| Q2 24 | $62.7M | $-79.0M | ||
| Q1 24 | $70.2M | $-193.9M |
| Q4 25 | 23.7% | -48.6% | ||
| Q3 25 | 29.0% | -58.0% | ||
| Q2 25 | 12.4% | -66.5% | ||
| Q1 25 | 28.4% | -120.5% | ||
| Q4 24 | 7.8% | -48.3% | ||
| Q3 24 | 31.7% | -49.2% | ||
| Q2 24 | 35.8% | -53.7% | ||
| Q1 24 | 38.0% | -178.2% |
| Q4 25 | 1.1% | 0.5% | ||
| Q3 25 | 0.4% | 0.8% | ||
| Q2 25 | 0.2% | 1.5% | ||
| Q1 25 | 0.5% | 1.0% | ||
| Q4 24 | 1.3% | 0.1% | ||
| Q3 24 | 0.6% | 1.2% | ||
| Q2 24 | 0.5% | 1.4% | ||
| Q1 24 | 0.2% | 3.0% |
| Q4 25 | 2.44× | — | ||
| Q3 25 | 3.78× | — | ||
| Q2 25 | 1.76× | — | ||
| Q1 25 | 6.30× | — | ||
| Q4 24 | 17.13× | — | ||
| Q3 24 | 2.03× | — | ||
| Q2 24 | 3.93× | — | ||
| Q1 24 | 3.11× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PRGS
| Maintenanceand Services | $187.5M | 74% |
| Share File Acquisition | $67.5M | 27% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
